Adaptive immune regulation of HSV-2 infection: from acute infection to latency and reactivation
Virology · 2027-02 · 626 · 111149
DOI: 10.1016/j.virol.2026.111149 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Virology, 2027-02. Verfasst von Melika Verdipanah und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Canada. Electronic address: verdipam@myumanitoba.ca. Die Arbeit nennt 165 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Herpes simplex virus type 2 (HSV-2) establishes lifelong infection through cycles of epithelial replication, neuronal latency, and periodic reactivation. While robust immune responses do not lead to viral clearance, they do play a central role in limiting the tissue impact of ongoing virus shedding that is part of the natural history of HSV-2. In sensory ganglia, CD8+ T cells suppress viral reactivation through non-cytolytic mechanisms, allowing persistence of latent viral genomes. At mucosal sites, tissue-resident memory T cells (TRM cells) provide rapid, localized responses that help contain viral spread. However, HSV-2 replication in epithelial tissues occurs rapidly and can outpace the activation and recruitment of circulating immune cells, creating a temporal mismatch that permits viral shedding despite immune surveillance. These findings suggest that HSV-2 persistence confers a kinetic and spatial advantage over immune responses, underscoring the need for next-generation vaccines and therapeutic strategies that enhance tissue-localized, early immune control and target latent viral reservoirs. This review examines HSV-2 infection as a continuous immunological process across epithelial and neuronal compartments and discusses its implications for vaccine development and therapeutic intervention.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Canada. Electronic address: verdipam@myumanitoba.ca.
- Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Canada; Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa; Department of Medical Micr…
- Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Canada.
Zitieren
APA
Verdipanah, M., McKinnon, L. R., & Porto, B. N. (2027). Adaptive immune regulation of HSV-2 infection: from acute infection to latency and reactivation. Virology, 626, 111149. https://doi.org/10.1016/j.virol.2026.111149
Vancouver
Verdipanah M, McKinnon LR, Porto BN. Adaptive immune regulation of HSV-2 infection: from acute infection to latency and reactivation. Virology. 2027;626:111149. doi:10.1016/j.virol.2026.111149
BibTeX
@article{Verdipanah2027,
author = {Verdipanah, Melika and McKinnon, Lyle R and Porto, Barbara N},
title = {Adaptive immune regulation of HSV-2 infection: from acute infection to latency and reactivation},
journal = {Virology},
year = {2027},
volume = {626},
pages = {111149},
doi = {10.1016/j.virol.2026.111149}
}
EUVIMED